THIONAMIDE-ASSOCIATED NECROTIZING AUTOIMMUNE MYOPATHY (NAM) IN GRAVES’ DISEASE
A CASE REPORT
Keywords:
anti-thyroid drugs (ATDs), Thionamide, Necrotizing Autoimmune Myopathy (NAM), Graves’ disease, MyositisAbstract
CASE
Necrotizing Autoimmune Myopathy (NAM) has never been reported as a cause of myositis in thionamide-treated Graves’ disease (GD). A 21-year-old Thai female presented with a 12-month history of palpitations. A diagnosis of GD was confirmed by elevated serum anti-TSH receptor antibody. Methimazole (MMI) 20 mg/day was started. Eleven weeks after therapy, she complained of generalized muscle pain. Elevated serum CK level at 791 U/L (<170) was found. MMI was switched to Propylthiouracil (PTU) 450 mg/day but serum CK level further rose to 2,538 U/L with worsening myalgia. Radioactive iodine (RAI) 30 mCi was given and she developed hypothyroidism at 9 weeks after treatment. She unexpectedly developed rhabdomyolysis (peak serum CK level at 13,084 U/L) while having a mild COVID-19 infection at 10 weeks after RAI. Finally, the diagnosis of NAM was established based on muscle biopsy. Our case highlighted NAM as an unusual cause of thionamide-associated myositis.
Downloads
References
*
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Yotsapon Thewjitcharoen, Waralee Chatchomchuan, Sriurai Porramatikul, Prakit Anukoolwittaya, Rajata Rajatanavin, Thep Himathongkam
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.